Then, the developed PBPK-PD model was further used to simulate plasma concentrations (Figure 5C) and IPA (Figure 5D) of CLOP-AM after 300 mg loading dose followed by 75 mg maintenance dose to CAD patients with DM involving CYP2C19 phenotypes. Here, CYP2C19 is linked to diabetes mellitus.